Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence

Annika Luukkainen, Sanna Toppila-Salmi

Research output: Contribution to journalReview ArticleScientificpeer-review

Original languageEnglish
JournalCurrent opinion in allergy and clinical immunology.
Volume13
Issue number1
Pages (from-to)37-44
Number of pages8
ISSN1528-4050
DOIs
Publication statusPublished - 1 Feb 2013
MoE publication typeA2 Review article in a scientific journal

Bibliographical note

WOS:000312533200007
Volume:
Proceeding volume:

Fields of Science

  • 3111 Biomedicine

Cite this

@article{bbc8d03d4332414498fe05c5518c85b1,
title = "Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence",
keywords = "3111 Biomedicine",
author = "Annika Luukkainen and Sanna Toppila-Salmi",
note = "WOS:000312533200007 Volume: Proceeding volume:",
year = "2013",
month = "2",
day = "1",
doi = "10.1097/ACI.0b013e32835b350e",
language = "English",
volume = "13",
pages = "37--44",
journal = "Current opinion in allergy and clinical immunology.",
issn = "1528-4050",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "1",

}

Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence. / Luukkainen, Annika; Toppila-Salmi, Sanna.

In: Current opinion in allergy and clinical immunology., Vol. 13, No. 1, 01.02.2013, p. 37-44.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence

AU - Luukkainen, Annika

AU - Toppila-Salmi, Sanna

N1 - WOS:000312533200007 Volume: Proceeding volume:

PY - 2013/2/1

Y1 - 2013/2/1

KW - 3111 Biomedicine

U2 - 10.1097/ACI.0b013e32835b350e

DO - 10.1097/ACI.0b013e32835b350e

M3 - Review Article

VL - 13

SP - 37

EP - 44

JO - Current opinion in allergy and clinical immunology.

JF - Current opinion in allergy and clinical immunology.

SN - 1528-4050

IS - 1

ER -